IBSA Institut Biochimique
Switzerland - Lugano-PazzalloBiotechnology
Focus: IBSA is a Swiss-based specialty pharma company founded in 1945 with 1,001-5,000 employees, focused on treatments and nutraceuticals across neurology and gastroenterology. The company operates a diversified portfolio spanning pain management, fertility, and dermatology.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Employees
1001-5000
Open Jobs
0
About IBSA Institut Biochimique
AI assessmentNot HiringNo open roles listed right now. Follow IBSA Institut Biochimique to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
21 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$9M Part DStable
Peak8.7yr
Flagship product driving 78% of company revenue; topical NSAID formulation with proven efficacy in acute musculoskeletal pain, approaching 11-year LOE window.
Help build intelligence for IBSA Institut Biochimique
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.